Status:
COMPLETED
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
Lead Sponsor:
Stanford University
Conditions:
Osteoarthritis
Eligibility:
All Genders
45+ years
Phase:
PHASE2
Brief Summary
A 12 week trial of Adalimumab in subjects with active erosive inflammatory OA who have ahd an inadequate response to NSAID therapy
Eligibility Criteria
Inclusion
- Age 45 or older, \>/=2 tender and 2 swollen joints, inadequate response to NSAID therapy, hand radiographs with evidence of erosive changes, acceptable form of birth control
Exclusion
- Autoimmune arthropathy, History of psoriasis, Previous TNF therapy, current use of any DMARD, evidence of TB, history of Hep C, B, or HIV
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00185562
Start Date
June 1 2005
End Date
January 1 2006
Last Update
March 24 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305